These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Experimental compound mer-17 (frenquel): a new blocking agent against the development of LSD-25 psychosis. FABING HD Trans Am Neurol Assoc; 1955-1956; (80th Meeting):83-5. PubMed ID: 13312008 [No Abstract] [Full Text] [Related]
24. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid. SAVINI EC Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207 [No Abstract] [Full Text] [Related]
25. [Specific inhibition of serotonin effects by lysergic acid diethylamide and similar compounds]. CERLETTI A; KONZETT H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):146-8. PubMed ID: 13334586 [No Abstract] [Full Text] [Related]
26. Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system. SHORE PA; SILVER SL; BRODIE BB Experientia; 1955 Jul; 11(7):272-3. PubMed ID: 13241495 [No Abstract] [Full Text] [Related]
28. Effect of ergot drugs on Betta splendens. EVANS LT; GERONIMUS LH; KORNETSKY C; ABRAMSON HA Science; 1956 Jan; 123(3184):26. PubMed ID: 13281475 [No Abstract] [Full Text] [Related]
29. [Variations of the cholinergic activity of the cerebral cortex tissue caused by bulbocapnine, lysergic acid diethylamide and mescaline]. POLONI A; MAFFEZZONI G Sist Nerv; 1952; 4(6):578-81. PubMed ID: 13048791 [No Abstract] [Full Text] [Related]
30. [Psychological effects of lysergic acid monoethylamide (LAE 32)]. TONINI G; MONTANARI C G Psichiatr Neuropatol; 1955; 83(2):355-7. PubMed ID: 13251531 [No Abstract] [Full Text] [Related]
31. Model psychoses induced by LSD-25 in normals. II. Rorschach test findings. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):612-8. PubMed ID: 13325990 [No Abstract] [Full Text] [Related]
32. Psychological aspects of the LSD treatment of the neuroses. SANDISON RA J Ment Sci; 1954 Apr; 100(419):508-15. PubMed ID: 13175012 [No Abstract] [Full Text] [Related]
33. [Effects of diethylamide of lysergic acid on the psychic symptoms of schizophrenia; psychopathological study]. CALLIERI B; RAVETTA M Rass Studi Psichiatr; 1955; 44(1):39-88. PubMed ID: 13246040 [No Abstract] [Full Text] [Related]
34. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989 [No Abstract] [Full Text] [Related]
35. [Lysergic acid diethylamide in psychiatry]. BERTHIAUME M Union Med Can; 1956 May; 85(5):555-60. PubMed ID: 13325081 [No Abstract] [Full Text] [Related]
36. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application. FABING HD Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384 [No Abstract] [Full Text] [Related]
37. The effects of lysergic acid diethylamide on the excitability cycle of the lateral geniculate. EVARTS EV; MARSHALL WH Trans Am Neurol Assoc; 1955-1956; (80th Meeting):58-60. PubMed ID: 13312000 [No Abstract] [Full Text] [Related]
38. [Antagonism between LSD and 5-HT on the motor initiative of the fish (Carassius auratus)]. SACCHI U; GIANNIOTTI G Boll Soc Ital Biol Sper; 1956; 32(3-5):177-9. PubMed ID: 13342212 [No Abstract] [Full Text] [Related]
39. Electrophysiological analysis of psychotogenic drug action. II. General nature of lysergic acid diethylamide (LSD) action on central synapses. PURPURA DP AMA Arch Neurol Psychiatry; 1956 Feb; 75(2):132-43. PubMed ID: 13282533 [No Abstract] [Full Text] [Related]